Aa-Z2 triggers ROS-induced apoptosis of osteosarcoma by targeting PDK-1
Abstract Background Osteosarcoma (OS) is the most frequent cancer derived from bone, and the prognosis of OS is poor. Metabolic alterations have been previously reported to contribute to the development of OS, and arsenic compounds have been suggested to exhibit strong anti-OS effects. However, few...
主要な著者: | , , , , , , , , |
---|---|
フォーマット: | 論文 |
言語: | English |
出版事項: |
BMC
2023-01-01
|
シリーズ: | Journal of Translational Medicine |
主題: | |
オンライン・アクセス: | https://doi.org/10.1186/s12967-022-03862-1 |